Biomx Inc (PHGE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PHGE Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Biomx Inc manages cash inflows and outflows over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income0.09
Depreciation & amortization0.01
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation2.25
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Interest And Other Income-
Revaluation Ofcontingent Liabilities-
Operating Leases Liability-
Finance Expenseincome Net-
Effect Of Exchange Rate Changes On Cash And Cash Equivalents And Restricted Cash-
Gain Loss On Capital Loss Net-
Change In Contract Liability-
Gain Loss On Termination Of Lease-
Income From Change In Fair Value Of Warrants14.06
Deconsolidation Gain Or Loss Amount-1.86
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-0.51
Accounts Payable-1.15
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital1.42
Other Noncash Income (Expense)-0.38
Other net0.07
Payments for (Proceeds from) Other Operating Activities-10.23
Discontinued operations1.86
Net Cash flow from Operating Activities-6.58
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Uncollected Proceeds From Sale Of Property And Equipment-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-0.75
Interest in Subsidiaries and Affiliates-0.38
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.42
Discontinued operations0.00
Net Cash Flow from Investing Activities-1.55
Financing Activities
Short-term debt Net0.01
Other borrowing transactions-1.89
Long-term debt - borrowings0.66
Long-term debt - repayments-0.05
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.58
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net2.22
Proceeds From Sale Of Units Net Of Underwriting Discounts Paid-
Cash Acquired In Connection With Reverse Recapitalization Net-
Acquisition Of Treasury Stock-
Payments In Connection With Current Assets And Liabilities Acquired In Reverse Recapitalization Net-
Exercise Of Stock Options-
Issuance Of Common Stock Under Open Market Sales Agreements Net Of Issuance Costs-
Issuance Of Common Stock Under Open Market Sales Agreement Net Of Issuance Costs-
Proceeds From Issuance Of Common Stock Under Inducement Letter Agreements-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.53
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-6.59
Total Cash Flow-4.61
4 historic quarters locked

Sign in to unlock the full Biomx Inc cash flow history.

About Biomx Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-091780

Figures are derived from filed reports and may be restated. Historical data is subject to revision.